Shares of TAKE Solutions gained over 4 per cent on Wednesday after the company informed BSE that it has awarded a patent by the United States Patent and Trademark Office (USPTO) for its 'Method for Optimizing Clinical Data Standardization'. This process leverages the company's clinical accelerators to reduce the time taken to standardise trial data by over 50 per cent (when compared to standardisation without the accelerators), thus reducing time to market.
The share price of the global business technology solutions provider, closed 4.34 per cent higher at Rs 103.35. Meanwhile, it opened at Rs 99.30 and has touched an intra-day high and low of Rs 109.20 and 99.05 on Wednesday.
The BSE Sensex also closed 74.70 points lower at 27,729.67.
The promoters holding in the company stood at 68.36 per cent while institutions and non-institutions held 1.32 per cent and 30.32 per cent, respectively.
For the year ended March 2015, the company registered net profit of Rs 69.88 crore, up 20.48 per cent against Rs 58 crore a year ago.
Copyright©2024 Living Media India Limited. For reprint rights: Syndications Today